Skip to main content

Advertisement

SpringerLink
Log in

Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Antihistamines are the first-line treatment for chronic urticaria (CU). However, some CU patients are relatively refractory to antihistamines. The mechanism underlying the interindividual variation is still unknown. The α-chain of the high-affinity IgE receptor is crucial to the IgE-mediated allergic response. The present study is to investigate whether FCER1A polymorphisms are associated with the risk of CSU, and to determine whether these polymorphisms influence the therapeutic efficacy of nonsedating H1-antihistamines. 191 CSU patients treated by nonsedating H1-antihistamines monotherapy (including desloratadine, mizolastine or fexofenadine) were prospectively enrolled in this study. The response to antihistamines monotherapy was assessed by urticaria activity score (UAS7) after 4 weeks of treatment. FCER1A rs2298805, rs10908703 and rs2494262 genotypes were determined by Sequenom Mass Array technology or direct sequencing. There was significant difference in the allele frequency of rs2298805A between CSU patients and 177 healthy subjects (5.3 vs 10.2 %, P = 0.012, OR = 0.491, 95 % CI 0.278–0.865), and also significant difference in the allele frequency of rs2298805A between effective and ineffective groups (7.5 vs 1.0 %, P = 0.015, OR = 8.328, 95 %CI 1.1–63.039). In addition, rs2298805 polymorphism was significantly associated with total serum IgE concentrations (P = 0.011). There were no differences in the rs10908703 and rs2494262 either between CSU patients and healthy controls, or between effective and ineffective groups. These data suggest that rs2298805 might be associated with risk for CSU and the therapeutic efficacy of nonsedating H1-antihistamines in Chinese patients with CSU.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Akoglu G, Atakan N, Cakir B, Kalayci O, Hayran M (2012) Effects of low pseudoallergen diet on urticarial activity and leukotriene levels in chronic urticaria. Arch Dermatol Res 304:257–262

    Article  CAS  PubMed  Google Scholar 

  2. Alzoubi KH, Khabour OF, Al-Azzam SI, Mayyas F (2013) The role of multidrug resistance-1 (MDR1) variants in response to fexofenadine among Jordanians. Int J Clin Pharmacol Ther 51:880–887

    Article  CAS  PubMed  Google Scholar 

  3. Backes DM, Siddiq A, Cox DG, Calboli FC, Gaziano JM, Ma J, Stampfer M, Hunter DJ, Camargo CA, Michaud DS (2013) Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma. J Neurooncol 113:229–238

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Bae JS, Kim SH, Ye YM, Yoon HJ, Suh CH, Nahm DH, Park HS (2007) Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol 119:449–456

    Article  CAS  PubMed  Google Scholar 

  5. Bozek A, Krajewska J, Filipowska B, Polanska J, Rachowska R, Grzanka A, Jarzab J (2010) HLA status in patients with chronic spontaneous urticaria. Int Arch Allergy Immunol 153:419–423

    Article  CAS  PubMed  Google Scholar 

  6. Brzoza Z, Grzeszczak W, Rogala B, Trautsolt W, Moczulski D (2012) PTPN22 polymorphism presumably plays a role in the genetic background of chronic spontaneous autoreactive urticaria. Dermatology 224:340–345

    Article  CAS  PubMed  Google Scholar 

  7. Brzoza Z, Grzeszczak W, Rogala B, Trautsolt W, Moczulski D (2014) Possible contribution of chemokine receptor CCR2 and CCR5 polymorphisms in the pathogenesis of chronic spontaneous autoreactive urticaria. Allergol Immunopathol (Madr) 42:302–306

    Article  CAS  Google Scholar 

  8. Deschamps C, Dubruc C, Mentre F, Rosenzweig P (2000) Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model. Clin Pharmacol Ther 68:647–657

    Article  CAS  PubMed  Google Scholar 

  9. Di Lorenzo G, Pacor ML, Candore G, Listi F, Ditta V, Leto-Barone MS, D’Alcamo A, Martinelli N, Corrocher R, Caruso C (2011) Polymorphisms of cyclo-oxygenases and 5-lipo-oxygenase-activating protein are associated with chronic spontaneous urticaria and urinary leukotriene E4. Eur J Dermatol 21:47–52

    PubMed  Google Scholar 

  10. Granada M, Wilk JB, Tuzova M, Strachan DP, Weidinger S, Albrecht E, Gieger C, Heinrich J, Himes BE, Hunninghake GM, Celedon JC, Weiss ST, Cruikshank WW, Farrer LA, Center DM, O’Connor GT (2012) A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study. J Allergy Clin Immunol 129:840–845

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Henz BM (2001) The pharmacologic profile of desloratadine: a review. Allergy 56(Suppl 65):7–13

    Article  PubMed  Google Scholar 

  12. Humphreys F, Hunter JA (1998) The characteristics of urticaria in 390 patients. Br J Dermatol 138:635–638

    Article  CAS  PubMed  Google Scholar 

  13. Imanaga J, Kotegawa T, Imai H, Tsutsumi K, Yoshizato T, Ohyama T, Shirasaka Y, Tamai I, Tateishi T, Ohashi K (2011) The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans. Pharmacogenet Genomics 21:84–93

    Article  CAS  PubMed  Google Scholar 

  14. Kalow W (2002) Pharmacogenetics and personalised medicine. Fundam Clin Pharmacol 16:337–342

    Article  CAS  PubMed  Google Scholar 

  15. Kaplan AP, Greaves M (2009) Pathogenesis of chronic urticaria. Clin Exp Allergy 39:777–787

    Article  CAS  PubMed  Google Scholar 

  16. Kim SH, Ye YM, Lee SK, Park HS (2006) Genetic mechanism of aspirin-induced urticaria/angioedema. Curr Opin Allergy Clin Immunol 6:266–270

    Article  CAS  PubMed  Google Scholar 

  17. Lebrun-Vignes B, Diquet B, Chosidow O (2001) Clinical pharmacokinetics of mizolastine. Clin Pharmacokinet 40:501–507

    Article  CAS  PubMed  Google Scholar 

  18. Losol P, Yoo HS, Park HS (2014) Molecular genetic mechanisms of chronic urticaria. Allergy Asthma Immunol Res 6:13–21

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Ma Q, Lu AY (2011) Pharmacogenetics, pharmacogenomics, and individualized medicine. Pharmacol Rev 63:437–459

    Article  CAS  PubMed  Google Scholar 

  20. Mahachie JJ, Baurecht H, Rodriguez E, Naumann A, Wagenpfeil S, Klopp N, Mempel M, Novak N, Bieber T, Wichmann HE, Ring J, Illig T, Cattaert T, Van Steen K, Weidinger S (2010) Analysis of the high affinity IgE receptor genes reveals epistatic effects of FCER1A variants on eczema risk. Allergy 65:875–882

    Article  Google Scholar 

  21. Maurer M, Ortonne JP, Zuberbier T (2009) Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation. Allergy 64:581–588

    Article  CAS  PubMed  Google Scholar 

  22. Maurer M, Weller K, Bindslev-Jensen C, Gimenez-Arnau A, Bousquet PJ, Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CE, Greaves MW, Hide M, Kalogeromitros D, Kaplan AP, Saini SS, Zhu XJ, Zuberbier T (2011) Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report. Allergy 66:317–330

    Article  CAS  PubMed  Google Scholar 

  23. Mimura N, Nagata Y, Kuwabara T, Kubo N, Fuse E (2008) P-glycoprotein limits the brain penetration of olopatadine hydrochloride, H1-receptor antagonist. Drug Metab Pharmacokinet 23:106–114

    Article  CAS  PubMed  Google Scholar 

  24. Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M (2008) How to assess disease activity in patients with chronic urticaria? Allergy 63:777–780

    Article  CAS  PubMed  Google Scholar 

  25. Molimard M, Diquet B, Benedetti MS (2004) Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundam Clin Pharmacol 18:399–411

    Article  CAS  PubMed  Google Scholar 

  26. Ozkan M, Oflaz SB, Kocaman N, Ozseker F, Gelincik A, Buyukozturk S, Ozkan S, Colakoglu B (2007) Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 99:29–33

    Article  PubMed  Google Scholar 

  27. Palikhe NS, Kim SH, Ye YM, Hur GY, Cho BY, Park HS (2009) Association of CRTH2 gene polymorphisms with the required dose of antihistamines in patients with chronic urticaria. Pharmacogenomics 10:375–383

    Article  CAS  PubMed  Google Scholar 

  28. Potaczek DP, Michel S, Sharma V, Zeilinger S, Vogelberg C, von Berg A, Bufe A, Heinzmann A, Laub O, Rietschel E, Simma B, Frischer T, Genuneit J, Illig T, Kabesch M (2013) Different FCER1A polymorphisms influence IgE levels in asthmatics and non-asthmatics. Pediatr Allergy Immunol 24:441–449

    Article  PubMed  Google Scholar 

  29. Potaczek DP, Sanak M, Szczeklik A (2007) Additive association between FCER1A and FCER1B genetic polymorphisms and total serum IgE levels. Allergy 62:1095–1096

    Article  CAS  PubMed  Google Scholar 

  30. Sanada S, Tanaka T, Kameyoshi Y, Hide M (2005) The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria. Arch Dermatol Res 297:134–138

    Article  CAS  PubMed  Google Scholar 

  31. Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A (2013) Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: is there evidence for updosing? J Investig Allergol Clin Immunol 23(141–44):2–145

    Google Scholar 

  32. Sharma V, Michel S, Gaertner V, Franke A, Vogelberg C, von Berg A, Bufe A, Heinzmann A, Laub O, Rietschel E, Simma B, Frischer T, Genuneit J, Potaczek DP, Kabesch M (2014) A role of FCER1A and FCER2 polymorphisms in IgE regulation. Allergy 69:231–236

    Article  CAS  PubMed  Google Scholar 

  33. Simons FE (2004) Advances in H1-antihistamines. N Engl J Med 351:2203–2217

    Article  CAS  PubMed  Google Scholar 

  34. Staevska M, Popov TA, Kralimarkova T, Lazarova C, Kraeva S, Popova D, Church DS, Dimitrov V, Church MK (2010) The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol 125:676–682

    Article  CAS  PubMed  Google Scholar 

  35. Triggiani M, Giannattasio G, Balestrieri B, Granata F, Gelb MH, de Paulis A, Marone G (2004) Differential modulation of mediator release from human basophils and mast cells by mizolastine. Clin Exp Allergy 34:241–249

    Article  CAS  PubMed  Google Scholar 

  36. Weidinger S, Gieger C, Rodriguez E, Baurecht H, Mempel M, Klopp N, Gohlke H, Wagenpfeil S, Ollert M, Ring J, Behrendt H, Heinrich J, Novak N, Bieber T, Kramer U, Berdel D, von Berg A, Bauer CP, Herbarth O, Koletzko S, Prokisch H, Mehta D, Meitinger T, Depner M, von Mutius E, Liang L, Moffatt M, Cookson W, Kabesch M, Wichmann HE, Illig T (2008) Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS Genet 4:e1000166

    Article  PubMed Central  PubMed  Google Scholar 

  37. Xu M, Ju W, Hao H, Wang G, Li P (2013) Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance. Drug Metab Rev 45:311–352

    Article  CAS  PubMed  Google Scholar 

  38. Yin OQ, Shi XJ, Tomlinson B, Chow MS (2005) Effect of cyp2d6*10 allele on the pharmacokinetics of loratadine in chinese subjects. Drug Metab Dispos 33:1283–1287

    Article  CAS  PubMed  Google Scholar 

  39. Zhou J, Zhou Y, Lin LH, Wang J, Peng X, Li J, Li L (2012) Association of polymorphisms in the promoter region of FCER1A gene with atopic dermatitis, chronic urticaria, asthma, and serum immunoglobulin E levels in a Han Chinese population. Hum Immunol 73:301–305

    Article  CAS  PubMed  Google Scholar 

  40. Zuberbier T (2012) Chronic urticaria. Curr Allergy Asthma Rep 12:267–272

    Article  PubMed  Google Scholar 

  41. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Gimenez-Arnau A, Godse K, Goncalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul LA, Mathelier-Fusade P, Metz M, Nast A, Saini SS, Sanchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Maurer M (2014) The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 69:868–887

    Article  CAS  PubMed  Google Scholar 

  42. Zuberbier T, Asero R, Bindslev-Jensen C, Walter CG, Church MK, Gimenez-Arnau A, Grattan CE, Kapp A, Merk HF, Rogala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B, Maurer M (2009) EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 64:1417–1426

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We appreciate Dr. Kyle R. Convington (Human Genome Sequencing Center, Baylor College of Medicine, TX 77030, USA) for revising this paper. This work was supported by grants from the National Natural Science Foundation of China (81001217 to Jie Li, 81225013 and 81430075 to Xiang Chen), Graduate Innovation Project in Central south university of Hunan Province (2013zzts086 to AiyuanGuo) and Science and Technology Project of Hunan Province (2014SK3108 to Jie Li).

Conflict of interest

All the authors declare that they have no financial competing interests.

Author information

Authors and Affiliations

  1. Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China

    Aiyuan Guo, Wu Zhu, Chong Zhang, Mingliang Chen, Jianglin Zhang, Juan Su, Wangqing Chen, Yue Zhao, Siyu Yan, Yijing He, Xiang Chen & Jie Li

  2. Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor PLZ, Houston, TX, 77030, USA

    Shu Wen

  3. Institute of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, China

    Xiaoping Chen, Zhaoqian Liu & Honghao Zhou

Authors
  1. Aiyuan Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wu Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shu Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaoping Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mingliang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jianglin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Juan Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wangqing Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yue Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Siyu Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yijing He
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Zhaoqian Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Honghao Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Xiang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Jie Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xiang Chen or Jie Li.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, A., Zhu, W., Zhang, C. et al. Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients. Arch Dermatol Res 307, 183–190 (2015). https://doi.org/10.1007/s00403-014-1525-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-014-1525-z

Keywords

Search

Navigation